Coronavirus Demanding Focus Of US FDA’s Antiviral, Other Divisions

 
• By Derrick Gingery
  
Coronavirus
US FDA staff are working quickly to help sponsors start clinical trials for potential coronavirus therapeutics, Office of New Drugs Director Peter Stein said. • Source: Shutterstock

More from Product Reviews

More from Pink Sheet